AbbVie
ABBV
#27
Rank
$255.66 B
Marketcap
$144.60
Share price
2.03%
Change (1 day)
34.71%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Market capitalization of AbbVie (ABBV)

Market cap: $255.66 Billion

As of September 2022 AbbVie has a market cap of $255.66 Billion. This makes AbbVie the world's 27th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AbbVie from 2012 to 2022

End of year Market Cap

Year Market cap Change
2022$255.66 B6.81%
2021$239.37 B26.54%
2020$189.17 B44.47%
2019$130.94 B-3.95%
2018$136.33 B-11.7%
2017$154.39 B51.71%
2016$101.76 B6.7%
2015$95.37 B-8.42%
2014$104.14 B24.23%
2013$83.82 B55.32%
2012$53.97 B

End of Day market cap according to different sources

On Sep 28th, 2022 the market cap of AbbVie was reported to be:

$255.66 Billion
by Yahoo Finance
$255.66 Billion
by CompaniesMarketCap
$255.59 Billion
by Nasdaq
$255.66 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$249.35 B-2.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$317.71 B 24.27%๐Ÿ‡บ๐Ÿ‡ธ USA
$123.55 B-51.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$40.13 B-84.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$80.12 B-68.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$153.86 B-39.82%๐Ÿ‡บ๐Ÿ‡ธ USA
$180.30 B-29.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
$59.52 B-76.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
$9.83 B-96.15%๐Ÿ‡บ๐Ÿ‡ธ USA